34 results on '"Etra, Aaron"'
Search Results
2. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
3. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD
4. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
5. A Day 14 Endpoint for Acute GVHD Clinical Trials
6. Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients
7. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
8. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
9. Effective treatment of low-risk acute GVHD with itacitinib monotherapy
10. Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee
11. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
12. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
13. Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis
14. Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World Analysis
15. The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)
16. The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd
17. Acute Graft‐versus‐Host Disease
18. The utility of biomarkers in acute GVHD prognostication
19. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
20. De Novo Late Acute Gvhd: Incidence, Outcomes, and Impact of Biomarkers Compared to Classic Acute Gvhd
21. REPOGRAMING OF THE INTESTINAL IMMUNE CELL COMPARTMENT DEFINES THE RESPONSE TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN CROHNS DISEASE
22. Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy
23. SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia
24. Mo1537: COMBINATION AUTOLOGOUS STEM CELL TRANSPLANTATION AND VEDOLIZUMAB FOR REFRACTORY CROHN’S DISEASE
25. Pathogenic Germline Variants in Multiple Myeloma
26. Prognostic Value of Elafin in Acute Graft-Versus-Host Disease
27. P-063: Pathogenic germline variants in hereditary cancer genes in patients with Multiple Myeloma
28. 274 AUTOLOGOUS STEM CELL TRANSPLANT MAY “RESET” NOT ONLY THE IMMUNE SYSTEM BUT MICROBIOME STRUCTURE AND FUNCTION IN PATIENTS WITH CROHN'S DISEASE
29. 32 - De Novo Late Acute Gvhd: Incidence, Outcomes, and Impact of Biomarkers Compared to Classic Acute Gvhd
30. Amphiregulin, ST2, and REG3α Biomarker Risk Algorithms as Predictors of Non-Relapse Mortality in Patients with Acute GVHD
31. The MAGIC Algorithm Probability Predicts Long-Term Outcomes and Treatment Response to Second-Line Therapy for Acute Gvhd
32. A Day 14 Endpoint for Acute Gvhd Clinical Trials
33. Flares of Acute Graft-Versus-Host Disease: Mount Sinai Acute Gvhd International Consortium (MAGIC) Study
34. The reparative immunologic consequences of stem cell transplantation as a cellular therapy for refractory Crohn's disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.